Orchestra BioMed Rings the Nasdaq Stock Market Opening Bell
Orchestra BioMed (Nasdaq: OBIO) visits the Nasdaq MarketSite in Times Square. Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. In honor of the occasion, David Hochman, Chairman, CEO and Founder of Orchestra BioMed, rings the Opening Bell.